Stem Cell Research (Jun 2024)

Generation of two lymphoblastoid-derived induced pluripotent stem cell (iPSC) lines from patients with phenylketonuria

  • Desi Veleva,
  • Merve Ay,
  • Dmitry A. Ovchinnikov,
  • Andrew B.J. Prowse,
  • Minal J. Menezes,
  • Michael Nafisinia

Journal volume & issue
Vol. 77
p. 103407

Abstract

Read online

We employed a Sendai virus-based reprogramming method to transform human lymphoblastoid cell lines (LCL) derived from two individuals diagnosed with phenylketonuria (PKU) into induced pluripotent stem cells (iPSC). This reprogramming process involved the expression of the four Yamanaka factors: KLF4, OCT4, SOX2, and C-MYC. The resulting patient-specific iPSCs exhibited a normal karyotype and expressed endogenous pluripotent markers NANOG and OCT-4. Notably, these iPSCs demonstrated strong differentiation capabilities, giving rise to cell populations representing the ectoderm, endoderm, and mesoderm germ layers.

Keywords